RA CAPITAL MANAGEMENT, L.P. enters ADICET BIO, INC. with 959.03K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 4/13/2026ACC: 0001231919-26-000335
10% Owner
Since Feb 2026
959.03K
Baseline shares
0.00
Direct ownership
0 positions
1.15M
Derivative underlying
1 instrument
1
Security positions
959.03K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned959.03K
Total
959.03K indirect959.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 959.03K | Indirect |
| Total | 959.03K | 959.03K indirect |
Derivative Holdings1
Pre-Funded Warrant (Right to Buy)
IndirectUnderlying security
Common Stock
Underlying shares
1.15M
Shares owned
N/A
Exercise price
0.0001
Expiration
—
Exercise window
—
Total
Underlying
1.15M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Pre-Funded Warrant (Right to Buy) Indirect | Common Stock | 0.0001 | — | — | 1.15M | N/A |
| Total | 1.15M | 0.00 | ||||